pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,050 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
  • phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›COMPLETEDphase readoutNCT06479330: Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate

    Sponsor: Mondelēz International, Inc.. Phase: NA. Conditions: Gastrointestinal Tolerance, Healthy Population

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03991728: Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry

    Sponsor: AO Innovation Translation Center. Phase: . Conditions: Temporomandibular Joint Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05691465: Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Small Cell Neuroendocrine Carcinoma, Stage IVB Prostate Cancer AJCC v8

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07119567: Impact of Cocaine Use and Withdrawal on Sleep

    Sponsor: Hôpital le Vinatier. Phase: . Conditions: Cocaine Use Disorder

    full page →ctgov ↗
    ›NO_LONGER_AVAILABLEphase readoutNCT05779267: NRX-101 Expanded Access

    Sponsor: NeuroRx, Inc.. Phase: . Conditions: Bipolar Depression, Bipolar Affective Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07621900: Effects of Lokomat Training on Dynamic Postural Stability in Incomplete Spinal Cord Injury

    Sponsor: I.R.C.C.S. Fondazione Santa Lucia. Phase: NA. Conditions: Spinal Cord Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07495800: Weight and BMI Patterns in Biological Based IBD Patients and Its Finacial Impact

    Sponsor: Assiut University. Phase: . Conditions: Inflammatory Bowel Diseases Weight Changes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04911400: Effects of Class III Elastics on Stability of Orthopaedic Class III Correction

    Sponsor: Sydney Local Health District. Phase: NA. Conditions: Class III Malocclusion, Underbite

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07547592: Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma

    Sponsor: Yonsei University. Phase: PHASE2. Conditions: Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05779592: A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma

    Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Muscle-invasive Urothelial Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07341711: Long-term Adaptations of Skeletal Muscle After Hybrid Training

    Sponsor: University of Thessaly. Phase: NA. Conditions: Obesity & Overweight

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07289711: Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study

    Sponsor: Southeast University, China. Phase: . Conditions: Acute Respiratory Distress Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07542171: Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Early Colorectal Cancer, Non-curative Endoscopic Resection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00091871: A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Eosinophilia, Hypereosinophilic Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06498427: Adolescents' Well-being in Community-based Treatment Versus Residential Treatment

    Sponsor: Outcome Referrals, Inc.. Phase: . Conditions: Adolescent Well-Being, Mental Disorders, Severe

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07590427: Periosteal Muscular Flap in Reconstruction of Small and Medium Sized Defects at Floor of the Mouth

    Sponsor: Alexandria University. Phase: NA. Conditions: Maxillofacial Reconstruction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05991661: XKH001 Injection in Healthy Subjects

    Sponsor: Beijing Kanova Biopharmaceutical Co., LTD. Phase: PHASE1. Conditions: Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06804642: Spinal Cord Stimulation for Parkinson's Disease Rehabilitation

    Sponsor: University of Louisville. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06563570: The Effect of Teleyoga in Liver Transplant Patients

    Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Liver Transplant Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01276470: Environmental Risk Factors for the Anti-synthetase Syndrome

    Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: . Conditions: Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis, Juvenile Polymyositis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07619183: A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.

    Sponsor: Prime Gene Therapeutics Co., Ltd.. Phase: PHASE1. Conditions: Lichen Simplex Chronicus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06189183: Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: NA. Conditions: Thymus Neoplasms

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06854094: Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis Patients

    Sponsor: Ente Ospedaliero Cantonale, Bellinzona. Phase: . Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06857994: The Association Between Cognitive Function and Neuropathy in Individuals With Type 2 Diabetes

    Sponsor: Steno Diabetes Center Copenhagen. Phase: . Conditions: Peripheral Diabetic Neuropathy, Cardiovascular Autonomic Neuropathy, Cognitive Impairment, Diabetes Type 2

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04634266: TRICuspid Intervention in Heart Failure Trial

    Sponsor: LMU Klinikum. Phase: NA. Conditions: Heart Failure Attributable to Severe Tricuspid Regurgitation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03038022: Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

    Sponsor: Madrigal Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Heterozygous Familial Hypercholesterolemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06931522: Effects of Mat and Reformer Pilates in Multiple Sclerosis

    Sponsor: Gazi University. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07619222: Correlation and Prognostic Value of Body Composition, Cardiac Structure and Function in Patients With Different Heart Failure Subtypes

    Sponsor: Beijing Anzhen Hospital. Phase: . Conditions: Heart Failure

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07373951: Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis

    Sponsor: Ming Yang. Phase: . Conditions: Non-Small Cell Lung Cancer, Brain Metastases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06270251: Modeling Tic Change During Behavior Therapy for Tics

    Sponsor: University of Minnesota. Phase: NA. Conditions: Chronic Tic Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06289829: The Appropriate Remifentanil Dose for Optimal Insertion of Laryngeal Mask Airway in Adult Patients During Induction of General Anesthesia Using Remimazolam.

    Sponsor: Yonsei University. Phase: NA. Conditions: Adult, Laryngeal Masks, Remimazolam, Remifentanil

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07376031: Cervical Thermal Ablation to Treat Persistent HPV Infection

    Sponsor: Hvidovre University Hospital. Phase: NA. Conditions: Cervical Cancer Screening, HPV, Thermal Ablation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07656402: Role Model-Based Ethics Education and Moral Injury Prevention in Second-Year Medical Students

    Sponsor: Chun Lun Hsu. Phase: NA. Conditions: Moral Injury, Perceived Stress, Resilience, Ethics Education

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06736002: Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study

    Sponsor: Chin-Wei Huang. Phase: NA. Conditions: Epilepsy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07481045: Compensatory Inferior Turbinate Surgery in Septorhinoplasty

    Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Nasal Obstruction Septal Deviation Compensatory Inferior Turbinate Hypertrophy

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04222972: A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

    Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: RET-fusion Non Small Cell Lung Cancer, Lung Neoplasm, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases, Respiratory Tract Disease, Carcinoma, Bronchogenic, Bronchial Diseases, Head and Neck Neoplasms, Adenocarcinoma, Carcinoma, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07362095: Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)

    Sponsor: Zhujiang Hospital. Phase: PHASE1. Conditions: Acute Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07167277: The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail

    Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Pre-frail, Pre-Frail Older Adults, Cognition, Physical Function, Dietary Intake Assessment, MRI

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07593677: Motivating Activity Through Text Communications - Helping Adults Increase Movement

    Sponsor: University of Michigan. Phase: NA. Conditions: Physical Inactivity, Aging, Cognitive Ability, Behavior Change

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03604757: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

    Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07350057: A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: PHASE1. Conditions: GVHD (Acute or Chronic)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07386301: Open Membrane Technique as an Innovative Minimally Invasive Technique for Bone Augmentation

    Sponsor: Saint-Joseph University. Phase: NA. Conditions: Bone Graft, Keratinized Tissue

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07260812: KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

    Sponsor: TCRx Therapeutics Co.Ltd. Phase: PHASE1. Conditions: Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00119912: NORCCAP: Norwegian Colorectal Cancer Prevention Trial

    Sponsor: Norwegian Institute of Public Health. Phase: NA. Conditions: Colorectal Cancer, Adenoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07540312: A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome

    Sponsor: PGP Health. Phase: NA. Conditions: IBS (Irritable Bowel Syndrome)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05728281: Impact of Time on Sexual Function (FSFI® Score) After Hysterectomy

    Sponsor: University Hospital, Angers. Phase: NA. Conditions: Time Between Hysterectomy and Resumption of Sexual Relations, Sexual Function

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07481981: A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

    Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07594730: Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems

    Sponsor: New York State Psychiatric Institute. Phase: NA. Conditions: Depression Disorders, ADHD, Substance Abuse, Social Stigma, Help-Seeking Behavior, Caregiver Burden

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02361528: GM-CSF to Decrease ICU Acquired Infections

    Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Septic Shock, Severe Sepsis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07322328: Effect of Hypo-pressive Exercises and Pelvic Floor Muscle Training in Postpartum Stress Urinary Incontinence Women

    Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Stress Urinary Incontinence (SUI), Stress Urinary Incontinence in Women

    full page →ctgov ↗
    ← prev
    page 75 of 101
    next →